CMXHF (CMXHF) Stock Price & Analysis
CMXHF (CMXHF) fell 0.74% to USD 66 as of June 10, 2026 at 00:56 UTC, according to Nexqual real-time market data.
CMXHF last closed at USD 66.49; the session ranged USD 66–66 on volume of 100 shares. Market capitalization is $31.61B, with a 52-week range of USD 63.84–184.09 (OQX). Source: Nexqual, June 10, 2026 at 00:56 UTC.
Key Statistics (as of June 10, 2026 at 00:56 UTC)
| Price | USD 66 |
|---|---|
| Change | ▼ 0.74% (down) |
| Previous Close | USD 66.49 |
| Open | USD 66 |
| Day Range | USD 66 – 66 |
| 52-Week Range | USD 63.84 – 184.09 |
| Volume | 100 shares |
| Market Cap | $31.61B |
| Exchange | OQX |
Technical Analysis (CMXHF)
Nexqual's technical model rates CMXHF "SELL" based on 1 bullish and 4 bearish signals across 123 daily candles, as of June 10, 2026 at 00:56 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 40.1 (neutral) |
| vs SMA50 | Below (USD 84.45) |
| MACD | -4.69 (negative) |
Analyst Ratings (CMXHF)
Wall Street analysts rate CMXHF "None", per Nexqual as of June 10, 2026 at 00:56 UTC.
| Consensus Rating | None |
|---|
Earnings (CMXHF)
Source: Nexqual, June 10, 2026 at 00:56 UTC.
Financials & Fundamentals (CMXHF)
| Total Revenue | $15.41B |
|---|---|
| Revenue Growth (YoY) | -1.80% |
| Gross Margin | +51.87% |
| Operating Margin | +31.65% |
| Profit Margin | +9.06% |
| ROE | +6.66% |
| Debt / Equity | 54.44 |
| Current Ratio | 2.57 |
| Total Cash | $1.14B |
| Total Debt | $11.14B |
| Free Cash Flow | $1.85B |
Source: Nexqual, June 10, 2026 at 00:56 UTC.
Financial Health Score (CMXHF)
Nexqual rates CMXHF's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 00:56 UTC.
| Growth | Solid — Revenue +5% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 52%, operating 32% |
| Balance Sheet | Strong — $1.14B cash vs $11.1B debt |
| Cash Flow | Solid — FCF $1.85B, 12% margin |
| Efficiency | Mixed — ROE 7%, ROA 6.6% |
Ownership (CMXHF)
| Insider Ownership | +0.03% |
|---|---|
| Institutional Ownership | +43.51% |
| Shares Outstanding | 478.91M |
| Float | 481.76M |
Source: Nexqual, June 10, 2026 at 00:56 UTC.
Leadership (CMXHF)
CMXHF is led by Gordon Naylor BEng (Hons), C.P.A., DipCompSc (age 62), CEO, MD & Director, per Nexqual as of June 10, 2026 at 00:56 UTC.
| CEO, MD & Director | Gordon Naylor BEng (Hons), C.P.A., DipCompSc (age 62) |
|---|---|
| Chief Financial Officer | Ken Lim (age 51) |
| Executive VP & COO | Mary Oates (age 62) |
| Senior Vice President of Research & Development Strategic Operations | Deirdre BeVard |
Major Backers & Investors (CMXHF)
Notable institutional backers of CMXHF include Fidelity, J.P. Morgan Exch-Trd Fd. TRT-JPMorgan BetaBuilders Developed Asia Paci, MFS SERIES TRUST I-MFS Research International Fund, according to Nexqual as of June 10, 2026 at 00:56 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.57% |
| J.P. Morgan Exch-Trd Fd. TRT-JPMorgan BetaBuilders Developed Asia Paci | 0.29% |
| MFS SERIES TRUST I-MFS Research International Fund | 0.23% |
| Charles Schwab | 0.22% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.65% |
| BlackRock | 1.07% |
Source: Nexqual, June 10, 2026 at 00:56 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CSLLY | CSL Ltd. | USD 17.44 | ▲ 1.87% |
| MKGAF | Merck KGaA | USD 159.71 | ▼ 2.48% |
| NPPXF | NTT Inc. | USD 0.9 | ▼ 2.17% |
| GNMSF | Genmab A/S | USD 249 | ▼ 0.18% |
| DGEAF | Diageo plc | USD 19.75 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:56 UTC. This page is informational and not investment advice.